Apolipoprotein A-I(Fin): Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 83-90

  Miettinen, Helena E ^a,b   Gylling, Helena ^b   Miettinen, Tatu A ^b   Viikari, Jorma ^c   Paulin, Lars ^a   Kontula, Kimmo ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

catabolism; gene expression; high density lipoprotein; mutation; reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MUTANT PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CASE REPORT; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; HYPOLIPOPROTEINEMIA; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; ADOLESCENT; DOMINANT GENE; GENETICS; MIDDLE AGED; PEDIGREE; POINT MUTATION;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEIN A-I; FEMALE; GENES, DOMINANT; HUMANS; HYPOLIPOPROTEINEMIAS; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION;

EID: 0030614849     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.83     Document Type: Article

References (20)

1. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1316.
2. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
3. Fielding CJ, Shore VG, Fielding PE. A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun. 1972;46:1493-1498.
4. Bielicki JK, Johnson WJ, Weinberg RB, Blick JM, Rothblat GH. Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol. J Lipid Res. 1992;33:1699-1709.
5. Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem. 1991;266:3080-3086.
6. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver DR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill Book Co; 1989:1251-1266.
7. Schaefer EJ. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. Arteriosclerosis. 1984;4:303-322.
8. Karathanasis SK. Apolipoprotein multigene family: tandem organization of apolipoprotein A-I, C-III and A-IV genes. Proc Natl Acad Sci USA. 1985;82:6374-6378.
9. Ng DS, Leiter LA, Vezina C, Connelly PW, Hegele RA. Apolipoprotein A-I Q(-2)X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. J Clin Invest. 1994;93:223-229.
10. Römling R, von Eckardstein A, Funke H, Motti C, Fragiacomo GC, Noseda G, Assmann G. A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. Arterioscler Thromb. 1994;14:1915-1922.
11. Assmann G, von Eckardstein A, Funke H. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease: insights from mutations. Circulation. 1993;87(suppl III):III-28-III-34.
12. Deeb SS, Cheung MC, Peng R, Wolf AC, Stern R, Albers JJ, Knopp RH. A mutation in the human apolipoprotein A-I gene: dominant effect on the level and characteristics of plasma high density lipoproteins. J Biol Chem. 1991;266:13654-13660.
13. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics. 1990;8:318-323.
14. Franceschini G, Sirtori CR, Capurso A, Weisgraber KH, Mahley RW. A-I Milano apoprotein. J Clin Invest. 1980;66:892-900.
15. Weisgraber KH, Bersot TP, Mahley RW. A-I Milano apoprotein isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J Clin Invest. 1980;66:901-907.
16. Milano: detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem. 1983;258:2508-2513.
17. Franceschini G, Sirtori CR, Bosisio E, Gualandri V, Orsini GB, Mobavero AM, Capurso A. Relationship of the phenotypic expression of the A-I Milano apoprotein in plasma lipid and lipoprotein patterns. Atherosclerosis. 1985;58:159-174.
18. Ameli S, Hultgardh-Nilsson A, Cercek B, Shah PK, Forrester JS, Ageland H, Nilsson J. Recombinant apolipoprotein A-I Milano reduces intimai thickening after balloon injury in hypercholesterolemic rabbits. Circulation. 1994;90:1935-1941.
19. Lipid and lipoprotein analysis. In: Manuals of Laboratory Operations. Washington, DC: Lipid Research Clinic Program; 1974:63-70. US Dept of Health, Education, and Welfare publication NIH175-628.
20. Dobiasova M, Schutzova M. Cold labeled substrate and estimation of cholesterol esterification rate in lecithin cholesterol acyltransferase radioassay. Physiol Bohemoslov. 1986;35:319-327.